Maywufa Business Summary

Maywufa Co., Ltd. (1731.TW) operates a diversified business model centered on the manufacturing of personal care goods and the large-scale distribution of pharmaceuticals and medical supplies. The company generates revenue through three primary segments: Consumer Products, led by its flagship "Maywufa" brand which holds the leading market share in Taiwan’s hair dye and gray-hair coverage sectors; Pharmaceutical Distribution, managed via its "Pro-Pharmacy" (Boden) franchise network; and a specialized Medical Device and Supplement division. Its strategy utilizes an "Online Merge Offline" (OMO) approach to integrate extensive brick-and-mortar pharmacy channels with digital retail. Maywufa competes directly with domestic incumbents such as Nice Group, Hawley & Hazel (Darlie), and Namchow Holdings, as well as international giants like L'Oréal. Within this landscape, the company maintains a premium niche by applying pharmaceutical-grade R&D standards to consumer beauty products, leveraging deep penetration in Taiwan's aging-population healthcare market. The company was founded in 1976 by Chairman Lee Cheng-chia, a pharmacist by training from Kaohsiung Medical University and a former National Policy Advisor, who continues to lead the group's strategic vision. The current executive leadership is spearheaded by Vice Chairperson Elizabeth Lee (Lee Yi-ping), who holds an MBA from Rutgers University and has been instrumental in driving the firm’s digital transformation and expansion into the biotechnology sector. Key operational management is directed by General Manager Fred Lai (Lai Yu-ru), who oversees the group's multi-brand strategy and distribution partnerships. As the anchor of the Maywufa Bio-Tech Group, the company maintains significant strategic and board-level ties with its listed subsidiaries, PhytoHealth Corp and AmCad BioMed, positioning its leadership at the intersection of traditional retail and advanced medical innovation in botanical drugs and AI-driven diagnostics.